Dunn Edmund 4
4 · Monte Rosa Therapeutics, Inc. · Filed Mar 5, 2026
Insider Transaction Report
Form 4
Dunn Edmund
Principal Accounting Officer
Transactions
- Sale
Common Stock
[F1]2026-03-04$17.96/sh−139$2,496→ 22,554 total
Footnotes (1)
- [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
Signature
/s/ Phil Nickson, Attorney-in-Fact|2026-03-05